Trajectory, interactions, and predictors of higher symptom burden during induction therapy for multiple myeloma.

MLA

Kamal, Mona, et al. “Trajectory, Interactions, and Predictors of Higher Symptom Burden during Induction Therapy for Multiple Myeloma.” Journal of Patient-Reported Outcomes, vol. 8, no. 1, Dec. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s41687-024-00817-6.

APA

Kamal, M., Shi, Q., Shen, S.-E., Cleeland, C., & Wang, X. S. (2024). Trajectory, interactions, and predictors of higher symptom burden during induction therapy for multiple myeloma. Journal of Patient-Reported Outcomes, 8(1), 1–11. https://doi.org/10.1186/s41687-024-00817-6

Chicago

Kamal, Mona, Qiuling Shi, Shu-En Shen, Charles Cleeland, and Xin Shelley Wang. 2024. “Trajectory, Interactions, and Predictors of Higher Symptom Burden during Induction Therapy for Multiple Myeloma.” Journal of Patient-Reported Outcomes 8 (1): 1–11. doi:10.1186/s41687-024-00817-6.